S

Skin Research Institute | Clinical Research Site

Research site
(Unclaimed)
Location
4425 Ponce de Leon Boulevard, Suite 200, Coral Gables, Florida, United States of America

Site insights

Top conditions

Top treatments

MT10109L
OnabotulinumtoxinA
AGN-151586
PF-04965842
LIPO-202
AVP-786
Sofpironium Bromide
BOTOX
Izokibep
AXS-07

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 33 total trials

A Study to Assess Adverse Events and Change in Disease Activity of JUVÉDERM® VOLITE™ XC Injectable Gel for Change in Neck Appearance in Adult Participants

The cumulative effect of aging and environmental exposures (ie, ultraviolet, infrared, and visible light radiation and pollution) leads to wrinkles,...

Active, not recruiting
Neck Lines
Device: VOLITE XC

The masseter muscle is one of the muscles in the lower face used for chewing. The prominence of the masseter muscle can appear as a widened lower fac...

Enrolling
Masseter Muscle Prominence
Drug: Placebo
Drug: BOTOX

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide \[d6-DM\]/quinidine sulf...

Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786
Drug: Placebo

Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin 17A, to which it binds with high affinity. This study...

Active, not recruiting
Hidradenitis Suppurativa
Drug: Izokibep
Drug: Placebo

This is a multicenter, open-label trial to evaluate the efficacy and safety of AXS-07 in subjects with migraine attacks and prior inadequate response...

Enrolling
Migraine
Drug: AXS-07 (meloxicam-rizatriptan)

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Trial sponsors

Allergan logo
AbbVie logo
Galderma logo
Medytox logo
N
Pfizer logo
A
A
Axsome Therapeutics logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems